The study about the efficacy of the 23-valent pneumococcal polysaccharide vaccine among dialysis patients
Not Applicable
- Conditions
- chronic renal failure on dialysis
- Registration Number
- JPRN-UMIN000032511
- Lead Sponsor
- Tokatsu-Clinic Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
Not provided
Exclusion Criteria
No regular visits
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method First admission, or deaths due to all-cause pneumonia or cardiac events.
- Secondary Outcome Measures
Name Time Method